share is Baht 0.69 per share, increased from last year that showed at Baht 0.55 per share. According to the company’s Board of Director’s meeting, the meeting had approved to pay interim dividend for the
increased from 84.8 million Baht of year 2018 due to marketing expense for export business. 4. Finance Cost was 18.94 million baht decreased from Year 2018 of 20.81 million Baht due to lower in borrowing and
?Mobile App at the ready for investment?. The mobile application ?start-to-invest II? featuring a variety of enhancements is now downloadable through both IOS and Android mobile apps, without any expense
proportion in this asset class. However, the Company recorded gain on sale of investment in listed equity securities of Baht 5.46 million in this quarter. The Company recognized share of profit from
amounting to Baht 29.10 million. However, if the Company did not have this expense, the profit of quarter 4 in 2018 will be more that the profit of the same period in 2017. For share of loss from investments
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
the one- time expense, normalized EBITDA in 2Q19 was Bt19,753mn, increasing 4% YoY and 4. 5% QoQ, while normalized net profit was Bt8,234mn, increasing 2.9% YoY and 8. 1% QoQ. In conclusion for 1H19